


Power3 Medical Products, Inc. (OTCBB:PWRM.OB) is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
Alzheimer’s doesn’t have any immediate cure, but remedies for indicators can be found and investigate carries on. Even though current Alzheimer treatment options cannot cease Alzheimer’s disease from progressing, they’re able to temporarily decrease the speed of the deterioration involving signs of illness in addition to advance quality of life for the people with Alzheimer’s disease as well as all their caregivers. Today, there exists a international exertion under approach to finding better ways to take care of the condition, postponement its onset, and prevent it from escalating.
Power3 Medical Products recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, to name a few.
In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash.
More about PWRM at: www.Power3Medical.com
**************************************************************
Power-One Inc. (Nasdaq:PWER) announced that the jury has reached its verdict in SynQor v. Artesyn Technologies, Inc., et al. In 2007, SynQor filed a lawsuit in the United States District Court for the Eastern District of Texas, alleging that eleven defendants, including Power-One, infringed upon certain SynQor patents related to unregulated and semi-regulated bus converters and/or point of load (POL) converters used in intermediate bus architecture power supply systems. SynQor asserted 10 claims in 5 patents at trial, but withdrew its willfulness claims and its request for treble damages prior to trial.
Power-One, Inc. designs, manufactures, and markets power conversion and power management solutions for the renewable energy, communications infrastructure, and other high technology markets. Its products include alternate current (AC)/direct current (DC) power supplies that convert AC into DC voltage used primarily in networking systems, large scale data processors, and industrial equipment.
**************************************************************
Apogee Enterprises, Inc. (Nasdaq:APOG) announced fiscal 2011 third-quarter results. Apogee provides distinctive value-added glass solutions for the architectural and picture framing industries. Revenues of $147.2 million were down 18 percent. Operating loss was $1.8 million, compared to earnings of $16.1 million. Loss from continuing operations was $0.08 per share, versus earnings of $0.39 per share. Architectural segment revenues declined 21 percent, with an operating loss of $8.4 million. Backlog ended at $165.7 million, compared to $193.0 million at the end of the second quarter and $246.4 million at the end of the prior-year period.
Apogee Enterprises, Inc., through its subsidiaries, engages in the design and development of glass products, services, and systems. The company operates through two segments, Architectural Products and Services, and Large-Scale Optical Technologies. The Architectural Products and Services segment designs, engineers, fabricates, installs, maintains, and renovates the walls of glass, windows, storefront, and entrances comprising the outside skin of commercial and institutional buildings.
**************************************************************
Beacon Federal Bancorp, Inc. (Nasdaq:BFED) announced that Lisa M. Jones has been appointed Chief Financial Officer (”CFO”) of both the Company and the Bank effective January 1, 2011. As Senior Vice President and CFO, Ms. Jones is responsible for all aspects of the Company and Bank’s financial strategy and management. Commenting on the appointment of Ms. Jones, Chief Executive Officer Ross Prossner said, “I am proud of the development Lisa has made while at Beacon Federal. Lisa started her career at Beacon as a summer intern before graduating from LeMoyne College with a Bachelor of Science in Accounting.
Beacon Federal Bancorp, Inc. operates as the bank holding company for Beacon Federal that provides various banking services in New York, Massachusetts, Tennessee, and Texas. The company deposit products include savings accounts, health savings accounts, certificates of deposit, NOW accounts, money market accounts, non-interest bearing checking accounts, and individual retirement accounts.
**************************************************************

Orofino Gold Corp. (ORFG.PK) (”Orofino Gold” or the “Company”) has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.
The company newly announced that the Board Of Directors have appointed Mr. Ning Shi Long as Chairman of the Board and Executive Director.
Mr. Ary Fernando Pernett Marque has been appointed as the new President/CEO & Executive Director of Orofino Gold Corp. (see full resume on the company website at www.orofinogold.com)
Mr. Pernett will be responsible for all affairs of the Company in Colombia. Mr. Pernett has 30 years of experience working in the Colombian Mining sector and will over the near term choose his new development team to assist in the development of the company’s Senderos de Oro gold camp in the Sur de Bolivar Colombia.
The company and Mr. Pernett will continue to work with Contexto Legal of Medellin and Bogota, the company’s legal counsel as well as Discovery Consultants, (The Qualified 43-101 team) Canada, as they have in the past. The new team will now aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.
The Board of Director’s have accepted resignation of John T. Martin, former Managing Director of the Company. His resignation is effective immediately. The Company wish him well and success in future endeavors.

Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. The company has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. Orofino Gold Corp. was formerly known as SNT Cleaning, Inc. and changed its name to Orofino Gold Corp. in December 2009. The company was founded in 2005 and is based in Central, Hong Kong.
More about ORFG at:www.orofinogold.com
**************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).